“MYCOBACTERIAL SECRETORY PROTEOME WITH ES-31, ES-41, ES-43, ES-20, ES-38 AND ES-6 PROTEINS OF DIAGNOSTIC INTEREST AND SERINE PROTEASE AS CELL MARKER AND DRUG TARGET”
Journal Title: INTERNATIONAL JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH - Year 2014, Vol 2, Issue 5
Abstract
Tuberculosis (TB) remains a major threat to public health worldwide and has been declared as global emergency by WHO in 1993. According to the World Health Organization (WHO, 2009), 9 million new TB cases including 4 million smear positive cases with 15% HIVPositivity have been reported in 2007.
STUDY OF OXIDATIVE PARAMETERS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Background: Chronic obstructive pulmonary disease (COPD) proven fact as strong association with oxidative stress. Methods: Total number of 200 patients was studied, comprising of 100 healthy controls and 100 COPD cases....
A CASE OF UNICYSTIC AMELOBLASTOMA
Ameloblastomas are amongst most commonly occurring, locally aggressive, benign tumors of odontogenic origin worldwide. Unicystic ameloblastomas (UA) are the deceptive lesions of the jaw that mimics odontogenic cyst. Unic...
“BIOMARKERS DISCOVERY IN LATENT AND ACTIVE TB INFECTION”
Tuberculosis (TB) is a serious infectious disease. India has far more TB cases (active and latent) than any other country, which is bad enough. Recently, along with the increased incidence of TB, extra pulmonary TB [EPTB...
DETAILING THE SOFTWARE AIDED DESIGNING OF 3-D MODEL FOR MANDIBULAR RECONSTRUCTION: A CASE REPORT
The concept of using 3-D models in the field of oral and maxillofacial surgery is not new. On 8 August 1984, Charles W ‘Chuck’ Hull got the patent for creating an apparatus that creates 3-D replicas. It took 10 more year...
APPLICATION OF AUTOLOGOUS PLATELET RICH PLASMA (APRP) AS AN ADJUVANT THERAPY IN PLASTIC SURGERY
To study the role of Autologous Platelet Rich Plasma (APRP) as an adjunct therapy for various indications in plastic surgery. This is a retrospective analysis of 31 patients (7 groups) in whom APRP was given as an adjuva...